GlassScriptPhysician profile
Andrew Chang
NPI 1932594132
$1,703.65
in general payments reported to CMS, 2019-2025
21 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $39.41 · 2022: $281 · 2023: $281 · 2024: $938 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,383.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Immunitybio, INC. | $188.49 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $185.94 | 2024 | Adstiladrin |
| Myriad Genetic Laboratories, INC. | $171.72 | 2024 | Prolaris, Precisetumor |
| Urovant Sciences INC | $147.68 | 2022 | |
| Boston Scientific Corporation | $135.04 | 2023-2025 | Rezum Generator, Spaceoar System, General - Erectile Dysfunction |
| Pfizer INC. | $130.18 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $125.11 | 2023-2025 | Gemtesa, Orgovyx |
| Medtronic, INC. | $125.00 | 2024 | Interstim |
| Abbvie INC. | $120.70 | 2021-2025 | Lupron Depot |
| Astellas Pharma US INC | $95.07 | 2024 | Xtandi, Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $45.23 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $38.95 | 2024 | |
| Janssen Biotech, INC. | $38.51 | 2024-2025 | Erleada, Akeega |
| Dendreon Pharmaceuticals LLC | $31.50 | 2024 | Provenge |
| Tolmar, INC. | $28.77 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $26.37 | 2022-2023 | Lynparza |
| 180 Medical, INC. | $17.22 | 2024 | |
| Urogen Pharma, INC. | $13.92 | 2025 | |
| Myovant Sciences INC. | $13.45 | 2021 | |
| Bioprotect Medical, INC. | $13.18 | 2024 | Bioprotect Balloon Implant System |
| Allergan, INC. | $11.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Chang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.